From toxicity assessment to adaptive safety care: implementing comprehensive fast track safety evaluation for anticancer drug development ESMO Open Adverse Events in Clinical Trials Non Clinical Safety Evaluation and Adverse Events in Phase I Trials Pharmacovigilance Adverse Events (AEs): Identification, Reporting, and Management Clinical spectrum and evolution of immune checkpoint inhibitors toxicities over a decadea worldwide perspective eClinicalMedicine